Palisade Bio, Inc. (PALI)
1.665
-0.08
(-4.86%)
USD |
NASDAQ |
Jan 16, 16:00
1.70
+0.04
(+2.10%)
After-Hours: 19:49
Palisade Bio Market Cap: 248.42M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioMarin Pharmaceutical, Inc. | 10.49B |
| Amicus Therapeutics, Inc. | 4.420B |
| NovaBay Pharmaceuticals, Inc. | 1.866B |
| Palatin Technologies, Inc. | 16.58M |
| Theriva Biologics, Inc. | 6.583M |
Market Cap Related Metrics
| Price to Book Value | 77.39 |
| Price | 1.665 |
| Earnings Yield | -253.4% |